Kimia Farma
PT Kimia Farma Tbk is a state-controlled pharmaceutical company in Indonesia. Kimia Farma produces, markets and distributes chemicals, pharmaceuticals, biologic and other materials required for the production of pharmaceutical preparations, contraceptives, cosmetics, traditional medicines, health equipment, food/drink products, and other products including in the plantation and mining sectors.
Profil
| Industry Sector | Consumer Goods Industry |
| Industry Sub Sector | Pharmaceuticals |
| Established | 23 January 1969 |
| Listed | 4 July 2001 |
| Listed Company Code | KAEF |
| Listed Shares | 5,554,000,000 |
| Dividend | Yes |
| Major Shareholders (>5%) | Government of Indonesia (90.03%) |
| Key Subsidiaries | Kimia Farma Trading & Distribution Kimia Farma Apotek Sinkona Indonesia Lestari |
Stock Quote Kimia Farma - KAEF:
Business Summary
Kimia Farma has developed into a company with integrated health services in Indonesia. Its pharmaceutical business is supported by manufacturing, research and development, marketing, distribution, retail, and clinical laboratories and clinics.
Its products line include generics, consumer health products (herbal medicines and cosmetics), branded ethicals, antiretroviral, narcotics, contraceptive and raw materials.
Kimia Farma's Financial Highlights:
| 2014 | 2015 | 2016 | 2017 | |
| Net Sales | 4,521.0 | 4,860.4 | 5,811.5 | 6,127.5 |
| Gross Profit | 1,385.5 | 1,536.8 | 1,863.9 | 2,201.9 |
| Net Income | 234.6 | 255.9 | 267.4 | 326.8 |
| Income before Tax |
344.0 | 354.9 | 383.0 | 449.7 |
| Total Assets | 3,012.8 | 3,434.9 | 4,612.6 | 6,096.1 |
| Total Liabilities | 1,291.7 | 1,378.3 | 2,341.2 | 3,523.6 |
| Earnings per Share¹ |
46,08 | 47,07 | 48,15 | 58.84 |
| Cash Dividend per Share¹ |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
| Net Sales | 2,854.1 | 3,183.8 | 3,481.2 | 3,734.2 | 4,348.1 |
| Gross Profit | 788.3 | 904.5 | 1,038.0 | 1,175.2 | 1,292.2 |
| Net Income | 62.5 | 138.7 | 171.8 | 205.1 | 214.6 |
| Income before Tax |
99.7 | 178.6 | 232.0 | 278.3 | 284.1 |
| Total Assets | 1,565.8 | 1,657.3 | 1,794.4 | 2,076.3 | 2,514.7 |
| Total Liabilities | 570.5 | 543.3 | 541.7 | 634.8 | 1,018.2 |
| Earnings per Share¹ |
11,25 | 24,98 | 30,93 | 36,93 | 38,63 |
| Cash Dividend per Share¹ |
3,37 | 4,99 | 6,18 | 5,54 | 9,66 |
in billion IDR rupiah except stated otherwise
¹ in IDR rupiah
Source: Kimia Farma, Annual Report 2017
Projection Kimia Farma's Future Corporate Earnings:
| 2017 | 2018 | 2019F | 2020F | 2021F | |
| Revenues | 6,127.0 | 7,454.0 | 9,186.0 | 11,039.0 | 13,036.0 |
| EBITDA | 473.0 | 676.0 | 818.0 | 959.0 | 1,141.0 |
| Net Profit | 327.0 | 416.0 | 474.0 | 546.0 | 657.0 |
| P/E Ratio (x) | 52.2 | 41.0 | 36.0 | 31.2 | 26.0 |
| P/BV (x) | 6.8 | 5.3 | 4.7 | 4.2 | 3.7 |
in billion IDR, unless otherwise stated
Source: Danareksa Sekuritas (06.09.2019)
Lokasi
Detail Kontak
Jalan Veteran No. 9
Jakarta - 10110
Phone: +62 21 384 7709
Fax: +62 21 526 1508
Email: [email protected]
www.kimiafarma.co.id